NMIH vs VRTX · P/E 8.2, rev $651.0M vs P/E 30, rev $12.00B
NMI Holdings Inc (NMIH) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
NMI Holdings Inc (NMIH) is a insurance - specialty company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported NMIH revenue for 2024-12-31 was $651.0M. Net income was $360.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. NMIH currently screens at market cap $2.96B and trailing P/E 8.2.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
NMIH currently screens at market cap $2.96B and trailing P/E 8.2. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the NMIH and VRTX stock pages for the full models.
Not investment advice.